UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Identification and Optimization of EphA2-Selective Bicycles for the Delivery of Cytotoxic Payloads

Journal of medicinal chemistry, 2020-04, Vol.63 (8), p.4107-4116

2020

Volltextzugriff (PDF)

637 - ARQ-234: a high affinity CD200-Fc fusion protein for the treatment of atopic dermatitis

British journal of dermatology (1951), 2024-08, Vol.191 (Supplement_2)

2024

Volltextzugriff (PDF)

MMAE delivery using the Bicycle toxin conjugate BT5528

Molecular cancer therapeutics, 2020-07, Vol.19 (7), p.1385-1394

2020

Volltextzugriff (PDF)

Abstract 1319: Rapid accumulation of cytotoxic payload in tumor tissue drives BT5528 activity in tumor models

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.1319-1319

2021

Volltextzugriff (PDF)

Preclinical evaluation of [68Ga]Ga-BCY18469, a first-in-class EphA2-targeting radiotheranostic Bicyclic Peptide

Nuclear medicine and biology, 2023-11, Vol.126-127, p.108628, Article 108628

2023

Volltextzugriff (PDF)

Abstract 5854: BT5528, a Bicycle Toxin Conjugate targeting EphA2 has potent anti-tumor activity without bleeding or coagulation abnormalities in preclinical models

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.5854-5854

2018

Volltextzugriff (PDF)

Evaluation of the effort-related motivational effects of the novel dopamine uptake inhibitor PRX-14040

Pharmacology, biochemistry and behavior, 2016-09, Vol.148, p.84-91

2016

Volltextzugriff (PDF)

Comprehensive Surfaceome Profiling to Identify and Validate Novel Cell-Surface Targets in Osteosarcoma

Molecular cancer therapeutics, 2022-06, Vol.21 (6), p.903-913

2022

Volltextzugriff (PDF)

Abstract LB008: Integrative surfaceome profiling identifies immunotherapeutic targets in osteosarcomas (OS); Preclinical testing of BT1769, an MT1-MMP-targeted Bicycle Toxin Conjugate, in OS by the Pediatric Preclinical Testing Consortium (PPTC)

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.LB008-LB008

2021

Volltextzugriff (PDF)

Abstract 5855: Bicycle Drug Conjugates targeting EphA2 for the treatment of solid tumors: Discovery and selection of BT5528

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.5855-5855

2018

Volltextzugriff (PDF)

Development and preclinical characterization of a novel radiotheranostic EphA2-targeting bicyclic peptide

Theranostics, 2024-01, Vol.14 (12), p.4701-4712

2024

Volltextzugriff (PDF)

Abstract 5807: Bicycle Toxin Conjugates®for the treatment of solid tumors

Cancer research (Chicago, Ill.), 2024-03, Vol.84 (6_Supplement), p.5807-5807

2024

Volltextzugriff (PDF)

Recent advances in matrix metalloproteinase inhibitor research

Drug discovery today, 1996, Vol.1 (1), p.16-26

1996

Volltextzugriff (PDF)

Structure determination and analysis of human neutrophil collagenase complexed with a hydroxamate inhibitor

Biochemistry (Easton), 1995-10, Vol.34 (43), p.14012-14020

1995

Volltextzugriff (PDF)

Synthesis and Configuration of Some Hydroxymilbemycin Derivatives Including 22,23-Dihydroavermectin B1b Aglycone

Helvetica chimica acta, 1990-10, Vol.73 (7), p.1905-1917

1990

Volltextzugriff (PDF)

The application of molecular similarity calculations

Journal of computational chemistry, 1990-11, Vol.11 (10), p.1139-1146

1990

Volltextzugriff (PDF)

1.8‐Å Crystal Structure of the Catalytic Domain of Human Neutrophil Collagenase (Matrix Metalloproteinase‐8) Complexed with a Peptidomimetic Hydroxamate Primed‐Side Inhibitor with a Distinct Selectivity Profile

European journal of biochemistry, 1997-07, Vol.247 (1), p.356-363

1997

Volltextzugriff (PDF)

Inhibition of Matrix Metalloproteinases: An examination of the S1′ pocket

Bioorganic & medicinal chemistry letters, 1997-01, Vol.7 (2), p.193-198

1997

Volltextzugriff (PDF)

Synthesis and Configuration of Some Hydroxymilbemycin Derivatives Including 22,23‐Dihydroavermectin B 1b Aglycone

Helvetica chimica acta, 1990-10, Vol.73 (7), p.1905-1917

1990

Volltextzugriff (PDF)

High-Affinity Small Molecule Inhibitors of T Cell Costimulation: Compounds for Immunotherapy

Chemistry & biology, 2004-12, Vol.11 (12), p.1651-1658

2004

Volltextzugriff (PDF)

Ground-state diatomic potentials

Journal of the Chemical Society, Faraday Transactions 2, 1983, Vol.79 (2), p.323

1983

Volltextzugriff (PDF)

Ground-state diatomic potentials. Part 2.—Van der Waals molecules

J. Chem. Soc., Faraday Trans. 2, 1984, Vol.80 (11), p.1349-1361

1984

Volltextzugriff (PDF)

Sex differences in the burden of type 2 diabetes and cardiovascular risk across the life course

Diabetologia, 2019-10, Vol.62 (10), p.1761-1772

2019

Volltextzugriff (PDF)

Pulsed estrogen therapy prevents post-OVX porcine dura mater microvascular network weakening via a PDGF-BB-dependent mechanism

PloS one, 2013-12, Vol.8 (12), p.e82900

2013

Volltextzugriff (PDF)

Elucidating the Basis for Permissivity of the MT-4 T-Cell Line to Replication of an HIV-1 Mutant Lacking the gp41 Cytoplasmic Tail

Journal of virology, 2020-11, Vol.94 (23)

2020

Volltextzugriff (PDF)

1 – 25 von 45

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(39)

Publikationsform

Sprache

Englisch
(45)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Identification and Optimization of EphA2-Selective Bicycles for the Delivery of Cytotoxic Payloads

637 - ARQ-234: a high affinity CD200-Fc fusion protein for the treatment of atopic dermatitis

MMAE delivery using the Bicycle toxin conjugate BT5528

Abstract 1319: Rapid accumulation of cytotoxic payload in tumor tissue drives BT5528 activity in tumor models

Preclinical evaluation of [68Ga]Ga-BCY18469, a first-in-class EphA2-targeting radiotheranostic Bicyclic Peptide

Abstract 5854: BT5528, a Bicycle Toxin Conjugate targeting EphA2 has potent anti-tumor activity without bleeding or coagulation abnormalities in preclinical models

Evaluation of the effort-related motivational effects of the novel dopamine uptake inhibitor PRX-14040

Comprehensive Surfaceome Profiling to Identify and Validate Novel Cell-Surface Targets in Osteosarcoma

Abstract LB008: Integrative surfaceome profiling identifies immunotherapeutic targets in osteosarcomas (OS); Preclinical testing of BT1769, an MT1-MMP-targeted Bicycle Toxin Conjugate, in OS by the Pediatric Preclinical Testing Consortium (PPTC)

Abstract 5855: Bicycle Drug Conjugates targeting EphA2 for the treatment of solid tumors: Discovery and selection of BT5528

Development and preclinical characterization of a novel radiotheranostic EphA2-targeting bicyclic peptide

Abstract 5807: Bicycle Toxin Conjugates®for the treatment of solid tumors

Recent advances in matrix metalloproteinase inhibitor research

Structure determination and analysis of human neutrophil collagenase complexed with a hydroxamate inhibitor

Synthesis and Configuration of Some Hydroxymilbemycin Derivatives Including 22,23-Dihydroavermectin B1b Aglycone

The application of molecular similarity calculations

1.8‐Å Crystal Structure of the Catalytic Domain of Human Neutrophil Collagenase (Matrix Metalloproteinase‐8) Complexed with a Peptidomimetic Hydroxamate Primed‐Side Inhibitor with a Distinct Selectivity Profile

Inhibition of Matrix Metalloproteinases: An examination of the S1′ pocket

Synthesis and Configuration of Some Hydroxymilbemycin Derivatives Including 22,23‐Dihydroavermectin B 1b Aglycone

High-Affinity Small Molecule Inhibitors of T Cell Costimulation: Compounds for Immunotherapy

Ground-state diatomic potentials

Ground-state diatomic potentials. Part 2.—Van der Waals molecules

Sex differences in the burden of type 2 diabetes and cardiovascular risk across the life course

Pulsed estrogen therapy prevents post-OVX porcine dura mater microvascular network weakening via a PDGF-BB-dependent mechanism

Elucidating the Basis for Permissivity of the MT-4 T-Cell Line to Replication of an HIV-1 Mutant Lacking the gp41 Cytoplasmic Tail

Suchergebnisse filtern